Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protective Effect of Probacine Against Negative Gut Metabolism and Organ Dysfunction After Cardiovascular Surgery: A Randomized Controlled Trial

NCT04444362 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.

NCT NCT04444362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04444362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protective Effect of Probacine Against Negative Gut Metabolism and Organ Dysfunction After Cardiovascular Surgery: A Randomized Controlled Trial
Lead sponsor
Nanjing Medical University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
January 1, 2025
Completion date
December 31, 2026
Enrollment
500 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cardiopulmonary bypass, cardiovascular disease